Glucose-dependent expansion of pancreatic β-cells by the protein p8 in vitro and in vivo

American Journal of Physiology - Endocrinology and Metabolism

Volumn 291, Issue 6, 2006, Pages

  Päth, Günter ^a   Opel, Anne ^b   Gehlen, Martin ^b   Rothhammer, Veit ^b   Niu, Xinjie ^a   Limbert, Catarina ^b   Romfeld, Lars ^b   Hügl, Sigrun ^b   Knoll, Anita ^b   Brendel, Mathias D ^c   Bretzel, Reinhard G ^c   Seufert, Jochen ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

cell proliferation; Diabetes; Insulin secretion; Islet transplantation

Indexed keywords

AMYLIN; C PEPTIDE; GLUCOKINASE; GLUCOSE; GLUCOSE TRANSPORTER 2; ISOPROPYL THIOGALACTOSIDE; PROINSULIN; PROINSULIN I; PROTEIN P8; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR PDX 1;

ANIMAL CELL; ARTICLE; CELL DIVISION; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INSULIN RELEASE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STREPTOZOCIN DIABETES;

ADENOVIRIDAE; ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BLOOD GLUCOSE; BLOTTING, WESTERN; BODY WEIGHT; C-PEPTIDE; CELL COUNT; CELL PROLIFERATION; CELLS, CULTURED; DIABETES MELLITUS, EXPERIMENTAL; GLUCOSE; HUMANS; INSULIN; INSULIN-SECRETING CELLS; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; ISOPROPYL THIOGALACTOSIDE; KIDNEY; MICE; MICE, INBRED C57BL; NEOPLASM PROTEINS; ORGANISMS, GENETICALLY MODIFIED; PANCREAS; TRANSPLANTATION, HETEROLOGOUS;

EID: 33845445950     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00436.2005     Document Type: Article

References (45)

1. Bonner-Weir S, Deery D, Leahy JL, and Weir GC. Compensatory growth of pancreatic beta-cells in adult rats after short-term glucose infusion. Diabetes 38: 49-53, 1989.
2. Bonner-Weir S, Taneja M, Weir GC, Tatarkiewicz K, Song KH, Sharma A, and O'Neil JJ. In vitro cultivation of human islets from expanded ductal tissue. Proc Natl Acad Sci USA 97: 7999-8004, 2000.
3. Brandhorst H, Brandhorst D, Brendel MD, Hering BJ, and Bretzel RG. Assessment of intracellular insulin content during all steps of human islet isolation procedure. Cell Transplant 7: 489-495, 1998.
4. Bratland A, Risberg K, Maelandsmo GM, Gutzkow KB, Olsen OE, Moghaddam A, Wang MY, Hansen CM, Blomhoff HK, Berg JP, Fodstad O, and Ree AH. Expression of a novel factor, com1, is regulated by 1,25-dihydroxyvitamin D3 in breast cancer cells. Cancer Res 60: 5578-5583, 2000.
5. Buteau J, Foisy S, Rhodes CJ, Carpenter L, Biden TJ, and Prentki M. Protein kinase C-zeta activation mediates glucagon-like peptide-1-induced pancreatic beta-cell proliferation. Diabetes 50: 2237-2243, 2001.
6. Campagnoni CW, Landry CF, Pribyl TM, Schonmann V, Kampf K, Handley VW, Watson JB, Bongarzone ER, and Campagnoni AT. Identification of genes in the oligodendrocyte lineage through the analysis of conditionally immortalized cell lines. Dev Neurosci 23: 452-463, 2001.
7. Carty MD, Lillquist JS, Peshavaria M, Stein R, and Soeller WC. Identification of cis- and trans-active factors regulating human islet amyloid polypeptide gene expression in pancreatic beta-cells. J Biol Chem 272: 11986-11993, 1997.
8. Cousin SP, Hugl SR, Myers MG Jr, White MF, Reifel-Miller A, and Rhodes CJ. Stimulation of pancreatic beta-cell proliferation by growth hormone is glucose-dependent: signal transduction via janus kinase 2 (JAK2)/signal transducer and activator of transcription 5 (STAT5) with no crosstalk to insulin receptor substrate-mediated mitogenic signalling. Biochem J 344: 649-658, 1999.
9. Dickson LM, Lingohr MK, McCuaig J, Hugl SR, Snow L, Kahn BB, Myers MG Jr, and Rhodes CJ. Differential activation of protein kinase B and p70(S6)K by glucose and insulin-like growth factor 1 in pancreatic beta-cells (INS-1). J Biol Chem 276: 21110-21120, 2001.
10. Dickson LM and Rhodes CJ. Pancreatic beta-cell growth and survival in the onset of type 2 diabetes: a role for protein kinase B in the Akt? Am J Physiol Endocrinol Metab 287: E192-E198, 2004.
11. Diraison F, Parton L, Ferre P, Foufelle F, Briscoe CP, Leclerc I, and Rutter GA. Over-expression of sterol-regulatory-element-binding protein-1c (SREBP1c) in rat pancreatic islets induces lipogenesis and decreases glucose-stimulated insulin release: modulation by 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR). Biochem J 378: 769-778, 2004.
12. Dor Y, Brown J, Martinez OI, and Melton DA. Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation. Nature 429: 41-46, 2004.
13. Emamaullee JA, Rajotte RV, Liston P, Korneluk RG, Lakey JR, Shapiro AM, and Elliott JF. XIAP overexpression in human islets prevents early posttransplant apoptosis and reduces the islet mass needed to treat diabetes. Diabetes 54: 2541-2548, 2005.
14. Encinar JA, Mallo GV, Mizyrycki C, Giono L, Gonzalez-Ros JM, Rico M, Canepa E, Moreno S, Neira JL, and Iovanna JL. Human p8 is a HMG-I/Y-like protein with DNA binding activity enhanced by phosphorylation. J Biol Chem 276: 2742-2751, 2001.
15. Gahr S, Merger M, Bollheimer LC, Hammerschmied CG, Scholmerich J, and Hugl SR. Hepatocyte growth factor stimulates proliferation of pancreatic beta-cells particularly in the presence of subphysiological glucose concentrations. J Mol Endocrinol 28: 99-110, 2002.
16. Garcia-Montero AC, Vasseur S, Giono LE, Canepa E, Moreno S, Dagorn JC, and Iovanna JL. Transforming growth factor beta-1 enhances Smad transcriptional activity through activation of p8 gene expression. Biochem J 357: 249-253, 2001.
17. Georgia S and Bhushan A. Beta cell replication is the primary mechanism for maintaining postnatal beta cell mass. J Clin Invest 114: 963-968, 2004.
18. Goruppi S, Bonventre JV, and Kyriakis JM. Signaling pathways and late-onset gene induction associated with renal mesangial cell hypertrophy. EMBO J 21: 5427-5436, 2002.
19. Goruppi S and Kyriakis JM. The pro-hypertrophic basic helix-loop-helix protein p8 is degraded by the ubiquitin/proteasome system in a protein kinase B/Akt- and glycogen synthase kinase-3-dependent manner, whereas endothelin induction of p8 mRNA and renal mesangial cell hypertrophy require NFAT4. J Biol Chem 279: 20950-20958, 2004.
20. Hugl SR, White MF, and Rhodes CJ. Insulin-like growth factor I (IGF-I)-stimulated pancreatic beta-cell growth is glucose-dependent. Synergistic activation of insulin receptor substrate-mediated signal transduction pathways by glucose and IGF-I in INS-1 cells. J Biol Chem 273: 17771-17779, 1998.
21. Jiang YF, Vaccaro MI, Fiedler F, Calvo EL, and Iovanna JL. Lipopolysaccharides induce p8 mRNA expression in vivo and in vitro. Biochem Biophys Res Commun 260: 686-690, 1999.
22. Lu M, Seufert J, and Habener JF. Pancreatic beta-cell-specific repression of insulin gene transcription by CCAAT/enhancer-binding protein beta. Inhibitory interactions with basic helix-loop-helix transcription factor E47. J Biol Chem 272: 28349-28359, 1997.
23. Malicet C, Giroux V, Vasseur S, Dagorn JC, Neira JL, and Iovanna JL. Regulation of apoptosis by the p8/prothymosin alpha complex. Proc Natl Acad Sci USA: 2671-2676, 2006.
24. Malicet C, Lesavre N, Vasseur S, and Iovanna JL. p8 inhibits the growth of human pancreatic cancer cells and its expression is induced through pathways involved in growth inhibition and repressed by factors promoting cell growth. Mol Cancer 2: 37, 2003.
25. Mallo GV, Fiedler F, Calvo EL, Ortiz EM, Vasseur S, Keim V, Morisset J, and Iovanna JL. Cloning and expression of the rat p8 cDNA, a new gene activated in pancreas during the acute phase of pancreatitis, pancreatic development, and regeneration, and which promotes cellular growth. J Biol Chem 272: 32360-32369, 1997.
26. Mohammad HP, Seachrist DD, Quirk CC, and Nilson JH. Reexpression of p8 contributes to tumorigenic properties of pituitary cells and appears in a subset of prolactinomas in transgenic mice that hypersecrete luteinizing hormone. Mol Endocrinol 18: 2583-2593, 2004.
27. Motoo Y, Iovanna JL, Mallo GV, Su SB, Xie MJ, and Sawabu N. P8 expression is induced in acinar cells during chronic pancreatitis. Dig Dis Sci 46: 1640-1646, 2001.
28. Nielsen LL, Young AA, and Parkes DG. Pharmacology of exenatide (synthetic exendin-4): a potential therapeutic for improved glycemic control of type 2 diabetes. Regul Pept 117: 77-88, 2004.
29. Ohlsson H, Karlsson K, and Edlund T. IPF1, a homeodomain-containing transactivator of the insulin gene. EMBO J 12: 4251-4259, 1993.
30. Paris M, Bernard-Kargar C, Berthault MF, Bouwens L, and Ktorza A. Specific and combined effects of insulin and glucose on functional pancreatic beta-cell mass in vivo in adult rats. Endocrinology 144: 2717-2727, 2003.
31. Path G, Opel A, Knoll A, and Seufert J. Nuclear protein p8 is associated with glucose-induced pancreatic beta-cell growth. Diabetes 53, Suppl 1: S82-S85, 2004.
32. Ree AH, Tvermyr M, Engebraaten O, Rooman M, Rosok O, Hovig E, Meza-Zepeda LA, Bruland OS, and Fodstad O. Expression of a novel factor in human breast cancer cells with metastatic potential. Cancer Res 59: 4675-4680, 1999.
33. Ricordi C, Lacy PE, Finke EH, Olack BJ, and Scharp DW. Automated method for isolation of human pancreatic islets. Diabetes 37: 413-420, 1988.
34. Seufert J, Weir GC, and Habener JF. Differential expression of the insulin gene transcriptional repressor CCAAT/enhancer-binding protein beta and transactivator islet duodenum homeobox-1 in rat pancreatic beta cells during the development of diabetes mellitus. J Clin Invest 101: 2528-2539, 1998.
35. Su SB, Motoo Y, Iovanna JL, Berthezene P, Xie MJ, Mouri H, Ohtsubo K, Matsubara F, and Sawabu N. Overexpression of p8 is inversely correlated with apoptosis in pancreatic cancer. Clin Cancer Res 7: 1320-1324, 2001.
36. Su SB, Motoo Y, Iovanna JL, Xie MJ, Mouri H, Ohtsubo K, Yamaguchi Y, Watanabe H, Okai T, Matsubara F, and Sawabu N. Expression of p8 in human pancreatic cancer. Clin Cancer Res 7: 309-313, 2001.
37. Taieb D, Malicet C, Garcia S, Rocchi P, Arnaud C, Dagorn JC, Iovanna JL, and Vasseur S. Inactivation of stress protein p8 increases murine carbon tetrachloride hepatotoxicity via preserved CYP2E1 activity. Hepatology 42: 176-182, 2005.
38. Vasseur S, Folch-Puy E, Hlouschek V, Garcia S, Fiedler F, Lerch MM, Dagorn JC, Closa D, and Iovanna JL. p8 improves pancreatic response to acute pancreatitis by enhancing the expression of the anti-inflammatory protein pancreatitis-associated protein I. J Biol Chem 279: 7199-7207, 2004.
39. Vasseur S, Hoffmeister A, Garcia-Montero A, Barthet M, Saint-Michel L, Berthezene P, Fiedler F, Closa D, Dagorn JC, and Iovanna JL. Mice with targeted disruption of p8 gene show increased sensitivity to lipopolysaccharide and DNA microarray analysis of livers reveals an aberrant gene expression response. BMC Gastroenterol 3: 25, 2003.
40. Vasseur S, Hoffmeister A, Garcia-Montero A, Mallo GV, Feil R, Kuhbandner S, Dagorn JC, and Iovanna JL. p8-deficient fibroblasts grow more rapidly and are more resistant to adriamycin-induced apoptosis. Oncogene 21: 1685-1694, 2002.
41. Vasseur S, Vidal Mallo G, Fiedler F, Bodeker H, Canepa E, Moreno S, and Iovanna JL. Cloning and expression of the human p8, a nuclear protein with mitogenic activity. Eur J Biochem 259: 670-675, 1999.
42. Waeber G, Thompson N, Nicod P, and Bonny C. Transcriptional activation of the GLUT2 gene by the IPF-1/STF-1/IDX-1 homeobox factor. Mol Endocrinol 10: 1327-1334, 1996.
43. Watada H, Kajimoto Y, Umayahara Y, Matsuoka T, Kaneto H, Fujitani Y, Kamada T, Kawamori R, and Yamasaki Y. The human glucokinase gene beta-cell-type promoter: an essential role of insulin promoter factor 1/PDX-1 in its activation in HIT-T15 cells. Diabetes 45: 1478-1488, 1996.
44. Yoon KH, Quickel RR, Tatarkiewicz K, Ulrich TR, Hollister-Lock J, Trivedi N, Bonner-Weir S, and Weir GC. Differentiation and expansion of beta cell mass in porcine neonatal pancreatic cell clusters transplanted into nude mice. Cell Transplant 8: 673-689, 1999.
45. Zulewski H, Abraham EJ, Gerlach MJ, Daniel PB, Moritz W, Muller B, Vallejo M, Thomas MK, and Habener JF. Multipotential nestin-positive stem cells isolated from adult pancreatic islets differentiate ex vivo into pancreatic endocrine, exocrine, and hepatic phenotypes. Diabetes 50: 521-533, 2001.